KRAS and colorectal carcinoma: We utilized PICRUSt2 software to predict differential KEGG pathways between the gut microbiota of KRAS mutant and KRAS wild-type CRC patients, with the aim of identifying enriched biological pathways of gut microbiota associated with KRAS mutation status in CRC.